Business Description
Theriva Biologics Inc
NAICS : 325412
SIC : 2834
ISIN : US87164U1025
Description
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.76 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 36.8 | |||||
| 3-Year EPS without NRI Growth Rate | 44.3 | |||||
| 3-Year FCF Growth Rate | 42.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.2 | |||||
| 9-Day RSI | 48.41 | |||||
| 14-Day RSI | 46.81 | |||||
| 6-1 Month Momentum % | 1.84 | |||||
| 12-1 Month Momentum % | -28.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.07 | |||||
| Quick Ratio | 4.07 | |||||
| Cash Ratio | 3.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -80.3 | |||||
| Shareholder Yield % | -8.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -38.8 | |||||
| ROA % | -28.5 | |||||
| ROIC % | -64.04 | |||||
| ROC (Joel Greenblatt) % | -1012.9 | |||||
| ROCE % | -38.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.19 | |||||
| Price-to-Tangible-Book | 0.63 | |||||
| EV-to-EBIT | 0.53 | |||||
| EV-to-EBITDA | 0.53 | |||||
| EV-to-FCF | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 0.79 | |||||
| Price-to-Net-Cash | 0.93 | |||||
| Earnings Yield (Greenblatt) % | 188.68 | |||||
| FCF Yield % | -266.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:TOVX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Theriva Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.16 | ||
| Beta | 1.27 | ||
| Volatility % | 82.87 | ||
| 14-Day RSI | 46.81 | ||
| 14-Day ATR ($) | 0.037464 | ||
| 20-Day SMA ($) | 0.428638 | ||
| 12-1 Month Momentum % | -28.39 | ||
| 52-Week Range ($) | 0.1972 - 1.2 | ||
| Shares Outstanding (Mil) | 17.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Theriva Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Theriva Biologics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Theriva Biologics Inc Frequently Asked Questions
What is Theriva Biologics Inc(TOVX)'s stock price today?
The current price of TOVX is $0.42. The 52 week high of TOVX is $1.20 and 52 week low is $0.20.
When is next earnings date of Theriva Biologics Inc(TOVX)?
The next earnings date of Theriva Biologics Inc(TOVX) is 2024-05-10 Est..
Does Theriva Biologics Inc(TOVX) pay dividends? If so, how much?
Theriva Biologics Inc(TOVX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers